77 institutions reported holding $58.0M of CARDLYTICS (CDLX) in SEC 13F filings for 2026-06-30. Largest institutional holders: PenderFund Capital Management Ltd. ($15.5M), Context Capital Management, LLC ($12.4M), 683 Capital Management, LLC ($6.8M), CAPSTONE INVESTMENT ADVISORS, LLC ($4.6M), SUSQUEHANNA INTERNATIONAL GROUP, LLP ($3.8M). Source: SEC Form 13F.
Source: SEC Form 13F filings · as of 2026-06-30